Dr. Modesitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Emory Clinic at 1365 Clifton Rd
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 434-778-2471
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2002
- University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 1995 - 1999
- University of Virginia School of MedicineClass of 1995
- Emory University BS, Biology, Magna cum laude, 1987 - 1991
Certifications & Licensure
- VA State Medical License 2006 - 2026
- GA State Medical License 2022 - 2025
- KY State Medical License 2002 - 2007
- NC State Medical License 1996 - 2006
- TX State Medical License 2000 - 2002
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2022
- America's Top Doctors for Cancer Castle Connolly, 2011-2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer Start of enrollment: 2000 Nov 20
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer Start of enrollment: 2005 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology.Mary Katherine Anastasio, Pamela Peters, Jonathan Foote, Alexander Melamed, Susan C Modesitt
Gynecologic Oncology Reports. 2024-10-01 - The time is now: Concrete actions are needed to improve diversity and representation in clinical trials participation.Jhalak Dholakia, Susan C Modesitt
Gynecologic Oncology Reports. 2024-10-01 - Image analysis Uncovers associations between immune landscape, collagen structure, and neoadjuvant chemotherapy in high-grade serous ovarian carcinomas.Arpit Aggarwal, Germán Corredor, Pingfu Fu, Tilak Pathak, Tuomas Mirtti
Heliyon. 2024-07-15
Journal Articles
- Enhanced Recovery Program for Minimally Invasive and Vaginal Urogynecologic SurgeryDana L Redick, Traci L Hedrick, Susan C Modesitt, Robert H Thiele, Elisa Rodriguez Trowbridge, Kathie L Hullfish, International Urogynecology Journal
Press Mentions
- Could Total Mesometrial Resection Become a New Standard Treatment for Cervical Cancer?July 19th, 2024
- Surgeons Can Reduce Impact of Ovarian Cancer by Promoting Opportunistic SalpingectomiesMarch 14th, 2023
- Hair Straighteners: What’s the Impact on Uterine Cancer Risk?December 23rd, 2022
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: